Attention Deficit Hyperactivity Disorder Medications and Risk of Serious Cardiovascular Disease in Children and Youth. Effective Health Care Program Research Reports Number 35.

摘要

Recent reviews of U.S. Food and Drug Administration (FDA) Adverse Event Reporting System data have raised concern that attention-deficit hyperactivity disorder (ADHD) medication use might be associated with increased risk of serious cardiovascular disease. The objective of this document is to examine the association between use of ADHD medications and the risk for serious cardiovascular disease, including sudden cardiac death, acute myocardial infarction, and stroke, in children and youth of age 2-24 years.